Mihaylova, Borislava

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 4,854

2024 ESC Guidelines for the management of elevated blood pressure and hypertension

McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 2,298

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

Armitage, J., Baigent, C., Barnes, E., Betteridge, D. J., Blackwell, L., Blazing, M., Bowman, L., Braunwald, E., Byington, R., Cannon, C., et al. (2019) · The Lancet

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 801

Review of statistical methods for analysing healthcare resources and costs

Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics

Health Systems, Economic Evaluations, Quality of LifeStatistical Methods and Bayesian Inference

Cited by 767

2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Mach, F., Koskinas, K. C., Roeters van Lennep, J. E., Tokgözoğlu, L., Badimon, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., De Backer, G. G., et al. (2025) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 688

The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A.-P., Madero, M., Mihaylova, B., Tangri, N., et al. (2021) · Kidney International

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 581

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · Russian Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 325

Obesity and cardiovascular disease: An ESC clinical consensus statement

Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal

Cardiovascular Function and Risk FactorsObesity, Physical Activity, Diet

Cited by 313

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

Reith, C., Preiss, D., Blackwell, L., Emberson, J., Spata, E., Davies, K., Halls, H., Harper, C., Holland, L., Wilson, K., et al. (2024) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 161

Statins for people at low risk of cardiovascular disease – Authors' reply

Mihaylova, B., Emberson, J., Keech, A., Collins, R., & Baigent, C. (2012) · The Lancet

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 146

Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey

Thorn, J. C., Davies, C. F., Brookes, S. T., Noble, S. M., Dritsaki, M., Gray, E., Hughes, D. A., Mihaylova, B., Petrou, S., Ridyard, C., et al. (2021) · Value in Health

Health Systems, Economic Evaluations, Quality of LifeDelphi Technique in Research

Cited by 70

Is Doctor Referral to a Low‐Energy Total Diet Replacement Program Cost‐Effective for the Routine Treatment of Obesity?

Kent, S., Aveyard, P., Astbury, N., Mihaylova, B., & Jebb, S. A. (2019) · Obesity

Health Systems, Economic Evaluations, Quality of LifePharmacology and Obesity Treatment

Cited by 35

Healthcare utilisation and healthcare costs for patients with hypermobile spectrum disorders and coexisting functional dyspepsia and/or irritable bowel syndrome

Upadhyaya, A., Topan, R., Pandya, S., Williams, S., Fragkos, K., Zarate-Lopez, N., Roukas, C., Mihaylova, B., & Fikree, A. (2025) · Frontline Gastroenterology

Gastrointestinal motility and disordersHealth Systems, Economic Evaluations, Quality of Life

Cited by 1

Implementation of a learning health system for the management of non-communicable diseases in Thailand: a realist evaluation protocol

Marszalek, M., Wiwatkunupakarn, N., Buawangpong, N., Rinpon, K., Herber, N., Carvalho, C., Mihaylova, B., Nitsch, D., Mathur, R., Chantler, T., et al. (2026) · BMJ Open

Health Policy Implementation SciencePrimary Care and Health Outcomes

Cited by 0